ALKERMES PLC

ALKS

CIK 0001520262 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$385M
↓-10.6% -$45Mvs FY2024 (Q4)
Operating Income
$58M
↓-64.3% -$105Mvs FY2024 (Q4)
Net Income
$35M
↓-76.3% -$112Mvs FY2024 (Q4)
Gross Profit
$338M
↓-8.0% -$30Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
44/100
  • Profitability
    39ROIC 12.8% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 3.55 (above 1.5 = solid)
  • Leverage
    88D/E 0.24 (under 0.5 = conservative)
  • Efficiency
    35Asset Turnover 0.65x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -10.6% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Op Margin 15.1% · trend -9.9pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project ALKS's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$48.97
Total enterprise IV
$8.26B
Diluted shares
0.17B
Terminal PV
$5.99B (72% of total)
Year-5 FCF
$706M
YearProjected FCFDiscounted PV
+1$519M$472M
+2$560M$463M
+3$605M$455M
+4$653M$446M
+5$706M$438M
Terminal$9.65B$5.99B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$40M
investment in PP&E
Stock buybacks (TTM)
share count reduction
Stock-based comp (TTM)
$99M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$2.49B
everything owned
Total liabilities
$668M
everything owed
Stockholders' equity
$1.82B
shareholder claim
Net debt
$-103M
Net cash position ($103M)

Recent performance · 63 quarters

Revenue↓-10.6% -$45M
$385M
Net Income↓-66.3% -$97M
$49M
Free Cash Flow↓-5.8% -$11M
$170M
Operating Margin↓-22.7pts
15.1%

Drill down